Trade IMRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immuneering Corporation Class A (IMRX) is trading at US$4.44, down 1.00% today as of Sep 21, 13:52 EDT. The company has a market capitalisation of US$342.9M. Over the past 52 weeks, IMRX has traded between US$3.86 and US$10.08. On Syfe you can trade IMRX with $0 commission and add it to your watchlist.
| Previous close | US$4.48 |
|---|---|
| Market cap | US$342.9M |
| 52-week range | US$3.86 – US$10.08 |
| Volume | 1.08M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Immuneering Corporation Class A
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Year: 2021
HC Wainwright Initiates Immuneering at Buy With $14 Price Target
Aug 6, 11:18 AM · MT Newswires
Immuneering Names Andrew Gengos as CFO
Jun 15, 12:58 PM · MT Newswires
Immuneering's Phase 3 Trial of Atebimetinib Plus mGnP to Treat Pancreatic Cancer Doses First Patient
Jun 11, 12:24 PM · MT Newswires
Immuneering Corporation Class A (IMRX) stock is trading at US$4.44, -1.00% from the previous close of US$4.48.
The market cap for Immuneering Corporation Class A (IMRX) stock is approximately US$342.9M.
The 52-week high for Immuneering Corporation Class A (IMRX) stock is US$10.08.
The 52-week low for Immuneering Corporation Class A (IMRX) stock is US$3.86.
Immuneering Corporation Class A (IMRX) does not currently pay a dividend.
Stay on top of IMRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
